News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
XNK Therapeutics completes building phase of new GMP facility
Friday, September 02, 2022XNK Therapeutics AB XNK today announced the successful completion of the building phase of the companys new GMP clean room facility All equipment and systems are now installed and qualification of the clean room is complete while validation and quali...
Juniper Biologics Pte. Ltd. signs exclusive license agreement with Helsinn Healthcare SA for LEDAGA® (chlormethine) in Australia, Asia and the Middle East
Friday, September 02, 2022Helsinn Group a fully integrated global biopharma company with a diversified pipeline of innovative oncology assets and strong trackrecord of commercial execution and Juniper Biologics Pte Ltd a scienceled healthcare company focused on researching de...
Mymetics and PCI Biotech Sign a Preclinical Research Collaboration
Thursday, September 01, 2022Mymetics Corporation a pioneer in the research and development of virosome based vaccines and immunotherapies against infectious and life disabling diseases and PCI Biotech OSE PCIB a Norwegian cancer focused biopharmaceutical company have entered in...
Horizon Therapeutics plc Announces Plans to Expand its Development and Manufacturing Facility in Waterford, Ireland
Tuesday, August 30, 2022Horizon Therapeutics plc has announced the submission of a planning application to expand its development and manufacturing facility in Waterford Ireland The expansion aims to include new capabilities for drug substance biologics development and manu...
ANI Pharmaceuticals Announces the Launch of Prochlorperazine Maleate Tablets USP
Tuesday, August 30, 2022ANI Pharmaceuticals Inc today announced the launch of Prochlorperazine Maleate Tablets USP mg and mg ANIs Prochlorperazine Maleate Tablets USP mg and mg are the generic version of the Reference Listed Drug RLD Compazine and were developed in tech...
European Commission Approves FYB201/Ranivisio® (Ranivisio - Ranibizumab), a Biosimilar to Lucentis®
Monday, August 29, 2022Polpharma Biologics Group BV Formycon AG and Bioeq AG have announced that the European Commission EC has granted marketing authorization MA for Ranivisio Ranivisio Ranibizumab a biosimilar to Lucentis ranibizumabinjection in the European Union EU Th...
Biocytogen Expands Partnership with Merck
Friday, August 26, 2022Biocytogen Pharmaceuticals Beijing Co Ltd Biocytogen and Merck have entered into a global licensing agreement for the use of Biocytogens RenMice platform
GNS and Servier Announce AI Collaboration to Advance Multiple Myeloma Drug Discovery and Clinical Development
Thursday, August 25, 2022GNS a leading company in the field of biopharmaceutical drug discovery and development using Digital Twins and Causal AI biosimulation technology has announced a collaboration with Servier a global pharmaceutical group to advance efforts in Multiple...
LumaBridge and Parker Institute for Cancer Immunotherapy Announce Strategic Alliance to Streamline Immunotherapy Development
Thursday, August 25, 2022LumaBridge formerly known as Cancer Insight a clinical research organization CRO dedicated to discovering developing and testing emerging biotechnologies related to cancer therapies and the Parker Institute for Cancer Immunotherapy PICI the largest n...
Roche launches a digital PCR system, a powerful new diagnostics platform in the fight against cancer and other diseases
Wednesday, August 24, 2022Roche has unveiled the Digital LightCycler System their first digital polymerase chain reaction PCR system This advanced system is specifically designed to detect diseases and accurately quantify minuscule amounts of specific DNA and RNA targets that...
